Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

TB-500 (Ac-LKKTETQ) and Tesamorelin Interaction: Synergistic | Peptide Database

Can you take TB-500 (Ac-LKKTETQ) with Tesamorelin? Synergistic interaction (47% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

TB-500 (Ac-LKKTETQ)

Thymosin Beta-4 Active Fragment | Healing Peptide

TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take TB-500 (Ac-LKKTETQ) with Tesamorelin?

Yes, TB-500 (Ac-LKKTETQ) and Tesamorelin can generally be taken together. TB-500 (Ac-LKKTETQ) and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is TB-500 (Ac-LKKTETQ) and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between TB-500 (Ac-LKKTETQ) and Tesamorelin?

TB-500 (Ac-LKKTETQ) and Tesamorelin work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time TB-500 (Ac-LKKTETQ) and Tesamorelin?

TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question